Adjusted cumulative probability of 5-year breast cancer–specific mortality for aspirin users and nonusers in the full cohort and by lymph node status at diagnosis (positive, negative), adjusted for age, tumor stage, tumor grade, ER, PR, HER2, and comorbidity.